| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 42,14% | 21,51% | · | · |
| ARTEMIS US SELECT I ACC GBP | RVI USA | 42,12% | · | · | · |
| ARTEMIS US SELECT I INC GBP | RVI USA | 42,12% | · | · | · |
| BANKINTER EMERGENTES, FI R | RVI EMERGENTES | 42,12% | 68,83% | 38,97% | · |
| SCHRODER ISF GLOBAL ENERGY A ACC CHF | RVI ENERGÍA | 42,11% | 55,06% | 147,76% | 71,29% |
| AMUNDI FUNDS EMERGING WORLD EQUITY R2 EUR (C) | RVI EMERGENTES | 42,10% | 68,58% | 44,66% | · |
| BNY MELLON ASIAN INCOME FUND USD W (INC) | RVI ASIA EX-JAPÓN | 42,10% | 60,06% | 50,00% | 70,58% |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 42,08% | 21,09% | -22,48% | · |
| NINETY ONE GSF LATIN AMERICAN EQUITY FUND I ACC USD | RVI LATINOAMÉRICA | 42,08% | 33,52% | 31,46% | · |
| JPM EMERGING MARKETS DIVIDEND A (ACC) EUR | RVI EMERGENTES VALOR | 42,07% | 70,13% | 61,60% | 156,63% |
